O Hospital Geral de Santo António, antigamente Hospital Real de Santo António, localiza-se na antiga freguesia de Miragaia, na cidade e distrito do Porto, em Portugal, que integra o Centro Hospitalar e Universitário do Porto.

During the past decade, Centro Hospitalar do Porto conducted 132 clinical trials. In the 10-year time frame, 132 clinical trials started and 37 clinical trials were completed, i.e. on average, 28% percent of trials that started reached the finish line to date. In the past 5 years, 72 clinical trials started and 28 clinical trials were completed. i.e. 38.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centro Hospitalar do Porto" #1 sponsor was "Hoffmann-La Roche" with 18 trials, followed by "Amgen" with 9 trials sponsored, "Centro Hospitalar do Porto" with 9 trials sponsored, "Bayer" with 8 trials sponsored and "Boehringer Ingelheim" with 8 trials sponsored. Other sponsors include 92 different institutions and companies that sponsored additional 57 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Hospitalar do Porto" #1 collaborator was "Centro Hospitalar do Porto" with 5 trials as a collaborator, "Foundation for Science and Technology, Portugal" with 4 trials as a collaborator, "Eli Lilly and Company" with 3 trials as a collaborator, "Andaluz Health Service" with 2 trials as a collaborator and "AstraZeneca" with 2 trials as a collaborator. Other collaborators include 95 different institutions and companies that were collaborators in the rest 76 trials.

According to Clinical.Site data, the most researched conditions in "Centro Hospitalar do Porto" are "Carcinoma, Non-Small-Cell Lung" (6 trials), "Heart Failure" (4 trials), "Multiple Myeloma" (4 trials), "Breast Cancer" (3 trials) and "Cancer" (3 trials). Many other conditions were trialed in "Centro Hospitalar do Porto" in a lesser frequency.

Most popular intervention types in "Centro Hospitalar do Porto" are "Drug" (104 trials), "Other" (16 trials), "Device" (14 trials), "Biological" (6 trials) and "Behavioral" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (38 trials), "Atezolizumab" (9 trials), "Carboplatin" (6 trials), "Gemcitabine" (5 trials) and "Paclitaxel" (5 trials). Other intervention names were less common.

The vast majority of trials in "Centro Hospitalar do Porto" are 142 trials for "All" genders, 4 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Centro Hospitalar do Porto". undefined are not yet recruiting, 42 are recruiting, 36 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 53 completed trials in Centro Hospitalar do Porto, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Centro Hospitalar do Porto, 4 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 76 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 16 trials that are defined as “Not Applicable".

Centro Hospitalar do Porto has several departments that took part in Clinical trials: "Hospital Geral de Santo Antonio; Servico de Neurologia" - 9 trials